期刊文献+

银屑病皮损区肥大细胞分布和血管内皮细胞CD34表达的研究论 被引量:6

Study of distribution of mast cells and the expression on CD34 by vascular endothelial cells in psoriasis vulgaris
暂未订购
导出
摘要 目的:探讨肥大细胞(MC)和血管内皮细胞在银屑病发病中的作用。方法:采用组织化学和免疫组化的方法,观察寻常性银屑病皮损处MC和CD34标记血管内皮细胞的分布情况。结果:经甲苯胺蓝特殊染色发现,银屑病患者真皮区的MC密度在进行期(33.07±14.63)个/mm2,高于静止期(21.80±4.86)个/mm2,静止期又高于正常对照组(15.85±6.93)个/mm2,它们之间的差异均有显著性;免疫组化观察发现,银屑病真皮区CD34标记的微血管密度在进行期(29.31±4.04)个/mm2,明显高于静止期(22.31±2.07)个/mm2,而静止期又明显高于正常对照组(18.81±2.59)个/mm2。结论:寻常性银屑病皮损处真皮内肥大细胞和血管内皮细胞密度明显增加,且与病情变化有关。 Objective:To study the roles of mast cells and vascular endothelial cells in psoriatic lesions.Methods:The distributions of mast cells and CD34positive vascular endothelial cells were observed by using histochemical and immuno-histochemical methods.Results:A significantly higher density of mast cells and CD34positive vascular endothelial cells in the superficial dermis of the progressive psoriatic lesions was observed compared with that in the static psoriatic lesions.Conclusions:The density of mast cells and vascular endothelial cells in the superficial dermis of the psoriatic lesions is higher than that in the normal control,and is correlated with the severity of the disease.
出处 《临床皮肤科杂志》 CAS CSCD 北大核心 2004年第8期468-470,共3页 Journal of Clinical Dermatology
关键词 银屑病 肥大细胞 血管内皮细胞 CD34 psoriasis mast cell endothelial cells CD34
  • 相关文献

参考文献10

  • 1[1]Graven NM, Jackson CW, Kirby B, et al. Cytokine gene polymorphisms in psoriasis[J]. Br J Dermatol, 2001, 144(4): 849-853.
  • 2[2]Jiang WY, Chattedee AD, Raychaudhuri SP, et al. Mast cell density and IL-8 expression in nonlesional and lesional psoriatic skin[J]. Int J Dermatol, 2001, 40(11): 699-703.
  • 3[3]Hem S, Allen MH, Sousa AR, et al. Immunohistochemical evaluation of psoriatic plaques following selective photothermolysis of the superficial capillaries[J]. Br J Dermatol, 2001, 145(1): 45-53.
  • 4朱凡,郑敏,鲍彰.银屑病患者皮损中血管内皮生长因子受体的表达与血管增生的关系[J].中华皮肤科杂志,2003,36(7):365-367. 被引量:33
  • 5[5]Stassen M, Muller C, Richter C, et al. The streptococcal exotoxin streptolysin O activates mast cells to produce tumor necrosis factor alpha by p38 mitogen-activated protein kinase- and protein kinase C-dependent pathways[J]. Infect Immun, 2003, 71(11): 6171-6177.
  • 6[6]Kandere-Grzybowska K, Letournean R, Kempuraj D, et al. IL-1 induces vesicular secretion of IL-6 without degranulation from human mast cells[J]. J Immunol, 2003, 171(9): 4830-4836.
  • 7[7]Henz BM, Maurer M, Lippert U, et al. Mast cells as initiators of immunity and host defense[J]. Exp Dermatoll, 2001, 10(1): 1-10.
  • 8[8]Feoktistov I, Ryzhov S, Goldstein AE, et al. Mast cell-mediated stimulation ofangiogenesis: cooperative interaction between A2B and A3 adenosine receptors[J]. Circ Res, 2003, 92(5): 485-492.
  • 9[9]Tkaczyk C, Okayama Y, Woolhiser MR, et al. Activation of human mast cells through the high affinity IgG receptor[J]. Mol Immunol, 2002, 38(16-18): 1289-1293.
  • 10[10]Fieger CB, Sassetti CM, Rosen SD. Endoglycan, a member of the CD34 family, functions as an L-selectin ligand through modification with tyrosine sulfation and sialyl Lewis x [J]. J Biol Chem,2003, 278(30): 27390-27398.

二级参考文献9

  • 1Creamer JD, Barker JN. Vascular proliferation and angiogenic factors in psoriasis. Clin Exp Dermatol, 1995, 20: 6-9.
  • 2Lowe PM, Lee ML, Jackson CJ, et al. The endothelium in psoriasis.Br J Dermatol, 1995, 132: 497-505.
  • 3Detmar M, Brown LF, Claffey KP, et al. Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis. J Exp Med, 1994, 180: 1141-1146.
  • 4Strawn LM, McMahon G, App H, et al. Flk-1 as a target for tumor growth inhibition. Cancer Res, 1996, 56: 3540-3545.
  • 5Ferrara N, Carver-Moore K, Chen H, et al. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature, 1996, 380: 439-442.
  • 6Garcia RL, Coltrera MD, Gown AM. Analysis of proliferative grade using anti-PCNA/cyclin monoclonal antibodies in fixed, embedded tissues. Comparison with flow cytometric analysis. Am J Pathol,1989, 134: 733-739.
  • 7Strawn LM, McMahon G, App H, et al. Flk-1 as a target for tumor growth inhibition. Cancer Res, 1996, 56: 3540-3545.
  • 8郑敏,浙江大学医学院第二医院皮肤科.银屑病是细胞免疫介导性疾病?[J].中华皮肤科杂志,2002,35(2):85-87. 被引量:90
  • 9陈积愫,郑敏.寻常型银屑病患者血管内皮生长因子及单核细胞趋化因子-1表达的研究[J].中华皮肤科杂志,2002,35(2):111-113. 被引量:40

共引文献32

同被引文献78

引证文献6

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部